Viewing StudyNCT01125800



Ignite Creation Date: 2024-05-05 @ 10:32 PM
Last Modification Date: 2024-10-26 @ 10:20 AM
Study NCT ID: NCT01125800
Status: COMPLETED
Last Update Posted: 2017-03-20
First Post: 2010-05-12

Brief Title: A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Organization Data

Organization: Novartis
Class: INDUSTRY
Study ID: CLDE225X2104
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Novartis Pharmaceuticals
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators